Clinical trial Recruiting at 2 sites Interventional Ages 2 Months to 18

Maximizing laser therapy success for Port-Wine Birthmarks in kids

Official title: Maximizing Laser Therapy Success for Port-Wine Birthmarks in Pediatric Patients

Run by University of Texas Southwestern Medical Center · NCT07183644 · Data updated 2026-11-12

This study tests different laser treatment sequences to see which approach clears Port-Wine Stains in children with fewer sessions and less need for anesthesia.

Quick facts

Study typeInterventional
Ages2 Months to 18 Years
SexAll
Enrollment200 (estimated)
SponsorUniversity of Texas Southwestern Medical Center
Academic / other
Locations2 sites (Dallas, Texas and 1 other locations)
StatusRecruiting
StartedJuly 2026
Main results expectedSeptember 2028
Study endsSeptember 2028
Registry record updatedJune 5, 2026
Trial IDNCT07183644 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Candidates are children and adolescents aged 2 months to 18 years with a stable Port-Wine Stain who have no contraindications to laser therapy and whose guardians can provide consent.

Probably not a fit

Patients with active skin infections, recent laser therapy, photosensitizing medication use, anesthesia intolerance, or significant allergies to anesthesia may not benefit from this approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The trial compares five laser treatment modalities for Port-Wine Birthmarks in pediatric participants, using up to two sessions and selecting the most effective modality for follow-up until clearance or a plateau is reached. If no further improvement is seen, a second round with all modalities helps identify differences in efficacy between treatments and between primary and refractory cases. Outcomes will be analyzed to determine which modality or sequence provides the best results and whether refractory cases benefit differently. The study is interventional and seeks to optimize treatment efficiency and safety in the pediatric population.

Why it matters

Potential benefit: If successful, patients may achieve clearance with fewer treatment sessions and reduced anesthesia exposure.

How similar studies have gone: Previous studies have explored multiple laser modalities for Port-Wine Stains, but this trial aims to directly compare sequences and combinations to optimize outcomes.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Diagnosis of Port Wine Stain.
* Age Range: 2mo to 18 years of age.
* Stable PWS: The port wine stain should be stable, meaning there is no active inflammation or infection present, and it should not be changing in size or color due to factors like injury or disease.
* signed Consent: For ethical reasons, participants must be able to provide informed consent. In the case of minors, consent would generally be required from a parent or legal guardian.

General Health: Participants should generally be in good health, with no contraindications for laser therapy, such as certain skin conditions, infections, or hypersensitivity to light.

Exclusion Criteria:

* severe allergies to anesthesia
* active skin infections or inflammation
* recent laser therapy
* use of Photosensitizing medications
* participation in other laser studies

Where it's running

  • Children's Medical Center
    Dallas, Texas, United States
    Recruiting
  • Children's Medical Center
    Plano, Texas, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.